Sustiva and Glucose tolerance impaired - a phase IV clinical study of FDA data

Summary:

Glucose tolerance impaired is found among people who take Sustiva, especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Sustiva and have Glucose tolerance impaired. It is created by eHealthMe based on reports of 9,320 people who have side effects when taking Sustiva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jun, 30, 2022

9,320 people reported to have side effects when taking Sustiva.
Among them, 7 people (0.08%) have Glucose tolerance impaired.

What is Sustiva?

Sustiva has active ingredients of efavirenz. It is often used in hiv infection. eHealthMe is studying from 9,382 Sustiva users for its effectiveness, alternative drugs and more.

What is Glucose tolerance impaired?

Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis) is found to be associated with 1,181 drugs and 755 conditions by eHealthMe.

Number of Sustiva and Glucose tolerance impaired reports submitted per year:

Could Sustiva cause Glucose tolerance impaired?

Time on Sustiva when people have Glucose tolerance impaired *:

Gender of people who have Glucose tolerance impaired when taking Sustiva *:

female: 42.86 %
male: 57.14 %

Age of people who have Glucose tolerance impaired when taking Sustiva *:

Common drugs people take besides Sustiva *:

Common side effects people have besides Glucose tolerance impaired *:

Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 4 people, 57.14%
Renal Tubular Disorder (disease of kidney tubules): 4 people, 57.14%
Kidney Stones: 4 people, 57.14%
Glycosuria (excretion of glucose into the urine): 4 people, 57.14%
Blood Creatinine Increased: 4 people, 57.14%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 3 people, 42.86%
Weight Loss: 1 person, 14.29%
Insulin Resistance: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sustiva and have Glucose tolerance impaired?

Check whether Glucose tolerance impaired is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Sustiva:

Sustiva (9,382 reports)

Glucose tolerance impaired treatments and more:

Glucose tolerance impaired (9,167 reports)

COVID vaccines that are related to Glucose tolerance impaired:

How severe was Glucose tolerance impaired and when was it recovered:

Glucose tolerance impaired in Sustiva

Expand to all the drugs that have ingredients of efavirenz:

Glucose tolerance impaired and drugs with ingredients of efavirenz

Common drugs associated with Glucose tolerance impaired:

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz (the active ingredients of Sustiva) and Sustiva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.